Quick Heal Technologies (QUICKHEAL) Q2 24/25 earnings summary

Executive summary

• Achieved H1 FY25 revenue of ₹143.8 crore, up 10.8%-11% year-over-year, with strong growth in both consumer and enterprise segments.

• PAT surged to ₹8.2 crore in H1 FY25, a 5743% increase year-over-year, and EBITDA rose 237.7%-238% to ₹5.7 crore.

• Launched AntiFraud.AI, India's first comprehensive AI/ML-based B2C fraud prevention solution, expanding the product portfolio beyond antivirus.

• Maintains market leadership in Indian consumer antivirus with over 30% share and 9 million active devices protected.

• Focused on innovation, with nine patents, multiple product accolades, and ongoing investment in R&D and leadership.

Financial highlights

• Q2 FY25 consolidated revenue at ₹73.49 crore, up sequentially but down year-over-year; H1 FY25 revenue at ₹143.8 crore.

• H1 FY25 EBITDA at ₹5.7 crore, a turnaround from negative last year; PAT at ₹8.2 crore.

• Gross margin robust at 97% for H1 FY25; PAT margin improved to 5.7%.

• Cash and cash equivalents stood at ₹12.8 crore as of Sep 30, 2024.

• Market cap reached ₹35,449 Mn as of Sep 30, 2024.

Outlook and guidance

• Management expects continued growth, driven by new product launches, ongoing R&D investment, and operational efficiency.

• Focus on expanding serviceable market from ₹3,000 crore in FY25 to ₹4,000 crore by FY27, with new products and higher customer segments.

• No formal financial guidance provided, but focus remains on profitable growth and long-term value creation.